trending Market Intelligence /marketintelligence/en/news-insights/trending/us3hmmG75xYhVtP53xW9Bw2 content esgSubNav
In This List

Quadrivio & Pambianco-managed fund to inject capital into Rougj

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Podcast

Street Talk | Episode 99 - Higher rates punish bond portfolios, weigh on bank M&A

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Insight Weekly: CEO pay jumps; yield curve inversion deepens; wind giants lift turbine prices


Quadrivio & Pambianco-managed fund to inject capital into Rougj

A Quadrivio & Pambianco-managed private equity fund agreed to invest in Rougj, formally known as Laboratorio alla Borsa Srl.

The target company is focused on the formulation, production and distribution of cosmetic products in the pharmacy sector.

The investment will be made through The Made in Italy Fund through a combination of acquisition of shares and capital infusion. The company will use the investment in part to enter into strategic markets such as Germany, the U.K. and China.

Entrepreneurs Antonio Pirillo, Marco Giraldi and Alessandro Fier will continue to own a significant share in the business. Ettore Favia, who led the company in its latest development phase, will depart the company.

Legance and DLA Piper provided legal assistance to Quadrivio & Pambianco and Rougj, respectively. EY conducted accounting and tax due diligence.